Shaping the Future
of Respiratory Care
We are a medtech startup deeply committed to delivering top-notch cutting-edge respiratory care technology that pushes the boundaries of innovation to the future of healthcare
The World’s First Holistic
AI-Powered Pulmonology
Care System
EMILY.AI uses more than 40 parameters continuously monitored to customize long-term oxygen therapy in real-time, independent of the ongoing patient’s needs, the type of disease, localization, condition, or situation.
Our latest functional prototype has surpassed other automated closed-loop devices (maximum achieved 81% of the time in secure SpO2) by obtaining an 87% of the time secure SpO2.
Our explainable neural network algorithm applied to the upcoming version is expected to exceed 95% of the time in the secure SpO2 range.
Chronic Obstructive Pulmonary Disease (COPD)
Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes irreversible obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus (sputum) production and wheezing. It’s the most widespread respiratory disease, and the following information outlines its impact figures
Average annual direct cost of COPD patients in Europe requiring Long-Term Oxygen Therapy (LTOT)
Estimated total direct costs savings by using EMILY.AI
Oxygen therapy today
is based on a
100-year-old method
Patients who receive long-term oxygen therapy (LTOT) spend almost 60% of their time with impaired oxygen levels. Minimum 15 hours/day. This inadequate oxygen flow can lead to episodes of hypoxemia or hyperoxemia, that can have life threatening consequences:
Inadequate Oxygenation
Respiratory Distress
Organ Dysfunction
Exacerbation of Respiratory Conditions
Cardiac Strain
Delayed Recovery, Complications & Hospitalizations
EMILY, our dedicated pulmonologist powered by AI, is available 24/7 to evaluate your data and predict exacerbations up to 72 hours in advance.
Will help you manage your «disease» better than no one system available in the market
EMILY, our dedicated pulmonologist powered by AI, is available 24/7 to evaluate your data and predict exacerbations up to 72 hours in advance.
Will help you manage your «disease» better than no one system available in the market
How it works
Our team of top-notch healthcare, business, and technology experts is dedicated to upholding the highest standards in our field.
EXECUTIVE TEAM
Daniel Oliva
CEO & Founder
ExDeputy Director at Kosmos BTW others Multinational companies and entrepreneurship projects
Sara Heili, MD
Head Pulmonolgy of Fundación Jiménez Dïaz
Chief Medical Officer
4 times consecutive years Forbes Best 100 Doctors
Jaume Bordas, MD
Researcher
Researcher at IDIBELL & CIBERES
Pulmonologist at Bellvitge University Hospital
ADVISORS
Raimon Belenes, MD
Board Member, Partner & Promoter
A Benchmark in C-Level Health Management
Javier Viaña, PhD
Researcher in AI at MIT & Advisor
Best Paper in the US
Worked for NASA and THALES
Ramon Gomis, MD, PhD
Board Member & Research Strategy Advisor
exCEO at IDIBAPS
Board Member in Reig Jofre
Creu Sant Jordi Awarded
Supported by
